Cardinal Health (CAH) Projected to Post Quarterly Earnings on Thursday

Cardinal Health (NYSE:CAH) will likely be issuing its quarterly earnings data before the market opens on Thursday, January 30th. Analysts expect the company to announce earnings of $1.74 per share and revenue of $53.90 billion for the quarter. Cardinal Health has set its FY25 guidance at $7.75-7.90 EPS and its FY 2025 guidance at 7.750-7.900 EPS.Parties interested in listening to the company’s conference call can do so using this link.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The business had revenue of $52.28 billion during the quarter, compared to analyst estimates of $50.90 billion. During the same quarter in the prior year, the company posted $1.73 EPS. Cardinal Health’s quarterly revenue was down 4.3% compared to the same quarter last year. On average, analysts expect Cardinal Health to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Cardinal Health Trading Down 2.4 %

Shares of NYSE CAH opened at $127.59 on Wednesday. Cardinal Health has a 12 month low of $93.17 and a 12 month high of $131.29. The firm has a market capitalization of $30.88 billion, a PE ratio of 24.82, a price-to-earnings-growth ratio of 1.57 and a beta of 0.63. The firm has a fifty day simple moving average of $121.75 and a two-hundred day simple moving average of $113.66.

Cardinal Health Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were given a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. The ex-dividend date of this dividend was Thursday, January 2nd. Cardinal Health’s dividend payout ratio is currently 39.30%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CAH. TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and boosted their target price for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Morgan Stanley increased their target price on Cardinal Health from $127.00 to $136.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. Barclays increased their price objective on shares of Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft increased their target price on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Finally, Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a report on Tuesday, January 7th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $134.64.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.